These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Is it necessary to carry out hepatic resection and pulmonary resection to obtain a cure for liver and lung metastases from colorectal cancer ?].
    Author: Takahashi K, Matsumoto H, Nakano D, Watanabe F, Oohinata R, Iwanaga T, Oohashi M, Iwasaki Y, Yamaguchi T.
    Journal: Gan To Kagaku Ryoho; 2011 Feb; 38(2):187-92. PubMed ID: 21368482.
    Abstract:
    If hepatic or pulmonary metastases from colorectal cancer are resectable, we perform the operation, and the 5-year survival rate is 40-50%. Median survival time is over 20 months recently for systemic chemotherapy. However, surgical treatment is the only way to obtain a cure. RFA has the advantage of being minimally invasive. But the local recurrence rate is slightly high. It is important to detect a local recurrence early and perform repeated RFA. Repeated RFA improve the prognosis and get the same overall survival rate of liver resection. If both the hepatic and pulmonary metastases are resectable, we perform both resections, with a good surgical outcome. If we cannot perform a second metastasectomy after first metastasectomy, the prognosis is very poor compared to the prognosis for liver metastasis only or lung metastasis only. It is necessary to add many cases to decide the surgical indication for such cases of both liver and lung metastases.
    [Abstract] [Full Text] [Related] [New Search]